Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

239 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-21

Study Completion Date

2018-11-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups based on contrast dosing technique, and solid organ enhancement at uniphasic abdominal CT will be measured.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimization of Contrast Agent Dose in CT With Lean Body Weight

NCT03384979

Contrast Agent With Lean Body Weight

COMPLETED PHASE4

Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT

NCT02170688

IV Contrast Dosing

COMPLETED PHASE4

Comparison of Contrast Agent Administration Protocols

NCT04300972

Radiography, Thoracic

COMPLETED NA

Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations

NCT06965790

CT Scans Contrast Media Gender +1 more

RECRUITING NA

Chest CT Using Low-concentration Iodine Contrast Media

NCT05967117

Pulmonary Disease

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contrast Media Dosing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Total Body Weight

Group Type ACTIVE_COMPARATOR

Iohexol

Intervention Type DRUG

Iodinated contrast media

Lean Body Weight

Group Type ACTIVE_COMPARATOR

Iohexol

Intervention Type DRUG

Iodinated contrast media

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Iohexol

Iodinated contrast media

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* outpatients only
* patients scanned on modern Siemens scanners at our institution

Exclusion Criteria

* self-reported history of chronic kidney, heart or liver disease
* allergy to iodinated contrast
* acute illness
* outside maximum threshold limit for weight-based contrast dosing
* pregnancy
* image degradation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes